help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CHOI, J. K.
Right arrow Articles by TOMASZEWSKI, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CHOI, J. K.
Right arrow Articles by TOMASZEWSKI, J. E.

Am. J. Respir. Crit. Care Med., Volume 160, Number 3, September 1999, 1015-1018

Hyperacute Rejection of a Pulmonary Allograft
Immediate Clinical and Pathologic Findings

JOHN K. CHOI, JANE KEARNS, HAROLD I. PALEVSKY, KATHLEEN T. MONTONE, LARRY R. KAISER, CHESTER M. ZMIJEWSKI, and JOHN E. TOMASZEWSKI

Departments of Pathology and Laboratory Medicine, Medicine, and Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania

The clinical and pathologic findings seen in hyperacute rejection are well documented in renal and cardiac allografts. We describe the second case of hyperacute rejection in a pulmonary allograft and detail the immediate clinicopathologic findings. The patient underwent a single lung transplant for severe COPD with postoperative course complicated by acute rejection and graft failure. Eleven days later, the patient underwent a second transplant with intra-operative course complicated by rapid pulmonary edema and copious production of frothy, pink fluid from the bronchial orifice of the allograft followed by death within four hours of anastomoses. Intraoperative biopsy and autopsy demonstrated platelet/fibrin thrombi, marked interstitial neutrophilia, alveolar edema, and antibody deposition on the endothelial surface and vasculature walls. Prior to the first transplant, the patient's serum had 0% panel reactive antibody and was crossmatch compatible with the first allograft. The patient's serum prior to the second transplant contained cross-reacting antibodies to the donor's B and T lymphocytes. The immediate clinical findings in this case are similar to the findings in a previously reported case. This report is the first documentation of the immediate pathologic features of hyperacute rejection in a lung allograft which are similar to those seen with other organ allografts.




This article has been cited by other articles:


Home page
J Intensive Care MedHome page
C. L. Lau, G. A. Patterson, and S. M. Palmer
Critical Care Aspects of Lung Transplantation
J Intensive Care Med, March 1, 2004; 19(2): 83 - 104.
[Abstract] [PDF]


Home page
ChestHome page
D. S. Zander, M. A. Baz, G. A. Visner, E. D. Staples, W. H. Donnelly, A. Faro, and J. C. Scornik
Analysis of Early Deaths After Isolated Lung Transplantation
Chest, July 1, 2001; 120(1): 225 - 232.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society